Enhanced neurotrophin-3 bioactivity and release from a nanoparticle-loaded composite hydrogel
- PMID: 22510446
- DOI: 10.1016/j.jconrel.2012.03.024
Enhanced neurotrophin-3 bioactivity and release from a nanoparticle-loaded composite hydrogel
Abstract
Neurotrophin-3 (NT-3) has shown promise in regenerative strategies after spinal cord injury; however, sustained local delivery is difficult to achieve by conventional methods. Controlled release from poly(lactic-co-glycolic acid) (PLGA) nanoparticles has been studied for numerous proteins, yet achieving sustained release of bioactive proteins remains a challenge. To address these issues, we designed a composite drug delivery system comprised of NT-3 encapsulated in PLGA nanoparticles dispersed in an injectable hydrogel of hyaluronan and methyl cellulose (HAMC). A continuum model was used to fit the in vitro release kinetics of an NT-3 analog from a nanoparticle formulation. Interestingly, the model suggested that the linear drug release observed from composite HAMC was due to a diffusion-limiting layer of methyl cellulose on the particle surface. We then studied the effects of processing parameters and excipient selection on NT-3 release, stability, and bioactivity. Trehalose was shown to be the most effective additive for stabilizing NT-3 during sonication and lyophilization and PLGA itself was shown to stabilize NT-3 during these processes. Of four excipients tested, 400g/mol poly(ethylene glycol) was the most effective during nanoparticle fabrication, with 74% of NT-3 detected by ELISA. Conversely, co-encapsulation of magnesium carbonate with NT-3 was the most effective in maintaining NT-3 bioactivity over 28 days according to a cell-based axonal outgrowth assay. Together, the modeling and optimized processing parameters provide insight critical to designing a controlled bioactive release formulation for ultimate testing in vivo.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
-
Localized and sustained delivery of fibroblast growth factor-2 from a nanoparticle-hydrogel composite for treatment of spinal cord injury.Cells Tissues Organs. 2013;197(1):55-63. doi: 10.1159/000339589. Epub 2012 Jul 13. Cells Tissues Organs. 2013. PMID: 22796886
-
In vitro sustained release of bioactive anti-NogoA, a molecule in clinical development for treatment of spinal cord injury.Int J Pharm. 2012 Apr 15;426(1-2):284-290. doi: 10.1016/j.ijpharm.2012.01.035. Epub 2012 Jan 24. Int J Pharm. 2012. PMID: 22306041
-
Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury.Biomaterials. 2010 Oct;31(30):7631-9. doi: 10.1016/j.biomaterials.2010.07.004. Epub 2010 Jul 24. Biomaterials. 2010. PMID: 20656347
-
Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues.J Microencapsul. 1998 Nov-Dec;15(6):699-713. doi: 10.3109/02652049809008253. J Microencapsul. 1998. PMID: 9818948 Review.
-
Tunable Surface Charge Enables the Electrostatic Adsorption-Controlled Release of Neuroprotective Peptides from a Hydrogel-Nanoparticle Drug Delivery System.ACS Appl Mater Interfaces. 2023 Jan 11;15(1):91-105. doi: 10.1021/acsami.2c17631. Epub 2022 Dec 15. ACS Appl Mater Interfaces. 2023. PMID: 36520607 Review.
Cited by
-
Hydrogel systems and their role in neural tissue engineering.J R Soc Interface. 2020 Jan;17(162):20190505. doi: 10.1098/rsif.2019.0505. Epub 2020 Jan 8. J R Soc Interface. 2020. PMID: 31910776 Free PMC article. Review.
-
Polyethylene glycol in spinal cord injury repair: a critical review.J Exp Pharmacol. 2018 Jul 27;10:37-49. doi: 10.2147/JEP.S148944. eCollection 2018. J Exp Pharmacol. 2018. PMID: 30100766 Free PMC article. Review.
-
Extracellular Matrix-Mimetic Hydrogels for Treating Neural Tissue Injury: A Focus on Fibrin, Hyaluronic Acid, and Elastin-Like Polypeptide Hydrogels.Adv Healthc Mater. 2021 Nov;10(22):e2101329. doi: 10.1002/adhm.202101329. Epub 2021 Sep 8. Adv Healthc Mater. 2021. PMID: 34494398 Free PMC article. Review.
-
Hydrogel-based local drug delivery strategies for spinal cord repair.Neural Regen Res. 2021 Feb;16(2):247-253. doi: 10.4103/1673-5374.290882. Neural Regen Res. 2021. PMID: 32859771 Free PMC article. Review.
-
Assembly of protein-based hollow spheres encapsulating a therapeutic factor.ACS Chem Neurosci. 2013 Sep 18;4(9):1297-304. doi: 10.1021/cn400080h. Epub 2013 Jul 8. ACS Chem Neurosci. 2013. PMID: 23763540 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials